139 related articles for article (PubMed ID: 25393635)
1. From vitamin K antagonists to liver international normalized ratio: a historical journey and critical perspective.
Gatt A; Chen D; Pruthi RK; Kamath PS; Leise MD; Ashrani AA; Nichols WL; He R
Semin Thromb Hemost; 2014 Nov; 40(8):845-51. PubMed ID: 25393635
[TBL] [Abstract][Full Text] [Related]
2. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.
Tripodi A; Chantarangkul V; Primignani M; Fabris F; Dell'Era A; Sei C; Mannucci PM
Hepatology; 2007 Aug; 46(2):520-7. PubMed ID: 17659574
[TBL] [Abstract][Full Text] [Related]
3. The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index.
Magnusson M; Sten-Linder M; Bergquist A; Rajani R; Kechagias S; Fischler B; Németh A; Lindahl TL
Thromb Res; 2013 Sep; 132(3):346-51. PubMed ID: 23993902
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score.
Tripodi A; Chantarangkul V; Primignani M; Dell'Era A; Clerici M; Iannuzzi F; Aghemo A; Cazzaniga M; Salerno F; Mannucci PM
J Hepatol; 2009 Aug; 51(2):288-95. PubMed ID: 19501423
[TBL] [Abstract][Full Text] [Related]
5. The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions.
Tripodi A; Chantarangkul V; Mannucci PM
J Thromb Haemost; 2008 Feb; 6(2):243-8. PubMed ID: 17988228
[TBL] [Abstract][Full Text] [Related]
6. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.
Bellest L; Eschwège V; Poupon R; Chazouillères O; Robert A
Hepatology; 2007 Aug; 46(2):528-34. PubMed ID: 17654598
[TBL] [Abstract][Full Text] [Related]
7. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
[TBL] [Abstract][Full Text] [Related]
8. An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents.
Sermon AM; Smith JM; Maclean R; Kitchen S
Thromb Haemost; 2010 Apr; 103(4):757-65. PubMed ID: 20174759
[TBL] [Abstract][Full Text] [Related]
9. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
Isert M; Miesbach W; Schüttfort G; Weil Y; Tirneci V; Kasper A; Weber A; Lindhoff-Last E; Herrmann E; Linnemann B
Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986
[TBL] [Abstract][Full Text] [Related]
10. Laboratory Monitoring of Oral Vitamin K Anticoagulation.
Moffat KA; Lewis CW
Semin Thromb Hemost; 2017 Apr; 43(3):245-252. PubMed ID: 27677177
[TBL] [Abstract][Full Text] [Related]
11. Approaches to optimal dosing of vitamin K antagonists.
Witt DM
Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists.
Pottegård A; dePont Christensen R; Wang SV; Gagne JJ; Larsen TB; Hallas J
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1160-7. PubMed ID: 25250949
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease.
Lee JH; Kweon OJ; Lee MK; Lee HW; Kim HJ; Kim HR
Int J Hematol; 2015 Aug; 102(2):163-9. PubMed ID: 26068391
[TBL] [Abstract][Full Text] [Related]
14. Interlaboratory variability in assessment of the model of end-stage liver disease score.
Lisman T; van Leeuwen Y; Adelmeijer J; Pereboom IT; Haagsma EB; van den Berg AP; Porte RJ
Liver Int; 2008 Dec; 28(10):1344-51. PubMed ID: 18482269
[TBL] [Abstract][Full Text] [Related]
15. INR vs. thrombin generation assays for guiding VKA reversal: a retrospective comparison.
Herpers R; van Rossum AP; van Beem RT; Michel WM; Strijbis VJ; Strengers PF; Castel A; Brinkman HJ
Clin Chem Lab Med; 2015 Jul; 53(8):1227-36. PubMed ID: 25720079
[TBL] [Abstract][Full Text] [Related]
16. [The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].
Zelis M; Zweegman S; van der Meer FJ; Kramer MH; Smulders YM
Ned Tijdschr Geneeskd; 2008 May; 152(18):1042-6. PubMed ID: 18547025
[TBL] [Abstract][Full Text] [Related]
17. Drug-drug interactions between vitamin K antagonists and statins: a systematic review.
Engell AE; Svendsen ALO; Lind BS; Stage TB; Hellfritzsch M; Pottegård A
Eur J Clin Pharmacol; 2021 Oct; 77(10):1435-1441. PubMed ID: 33895864
[TBL] [Abstract][Full Text] [Related]
18. Thromboplastin standards.
van den Besselaar AM; Chantarangkul V; Tripodi A
Biologicals; 2010 Jul; 38(4):430-6. PubMed ID: 20338779
[TBL] [Abstract][Full Text] [Related]
19. Standardization of the INR: how good is your laboratory's INR and can it be improved?
Favaloro EJ; Adcock DM
Semin Thromb Hemost; 2008 Oct; 34(7):593-603. PubMed ID: 19085760
[TBL] [Abstract][Full Text] [Related]
20. Solving the mystery of excessive warfarin-induced bleeding: a personal historical perspective.
Hirsh J
Thromb Haemost; 2014 Nov; 112(5):853-6. PubMed ID: 25300199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
